Introduction cated by an additional class of neuroblastoma, referred to as 4S, that initially appears as a widely disseminated, Spontaneous lesions in the gene encoding the tumor aggressive disease (Ambros et al., 1995) . Remarkably, suppressor p53 have been implicated in the progression a majority of the 4S neuroblastomas suddenly and sponof a wide range of human tumors (Nigro et al., 1989;  taneously regress in the absence of treatment. UnderHollstein et al., 1991; Levine et al., 1995) . The prevalence standing these complex pathways of neuroblastoma inof tumors in individuals or mice bearing constitutional duction and progression will require the identification p53 mutations suggests that loss of p53 activity also of the provisional tumor suppressors located on the contributes to the generation of tumors (Li and Fraumeni, 1969; Malkin et al., 1990; Donehower et al., 1992 ; Jacks short arm of chromosome 1. et al., 1994) . Wild-type p53 can also be neutralized
We have identified a novel gene encoding a protein, through direct interaction with either cellular proteins or termed p73, with remarkable sequence similarity to the viral tumor antigens (Lane and Crawford, 1979; Linzer DNA-binding, transactivation, and oligomerization doand Levine, 1979; Werness et al., 1990 ). p53 appears mains of p53. We show that p73 has oligomerization to induce cell cycle arrest or apoptosis in response to and transactivation properties similar to p53 and that cellular stresses such as DNA damage and hypoxia the p73 gene maps to the 1p36.33 region frequently (Kastan et al., 1992; Livingstone et al., 1992; deleted in neuroblastoma and other tumors. In addition, al., 1993; Hartwell and Kastan, 1994) . By this means, we provide evidence to support the notion that alterations in p73 gene expression may be one factor in the development of neuroblastoma and other tumors. § To whom correspondence should be addressed. Primary amino acid sequences of human p73␣ and ␤ were deduced from cDNAs from normal human tissues.
(A) Comparative alignments of coding sequence and gene structure of human p73␣ and p53. Identities are enclosed in shaded boxes, with p53 residues frequently mutated in tumors presented in bold. The identity and position of introns within p73 and p53 genes are denoted above and below the respective sequences.
(B) C-terminal sequence of human p73␤, a splicing variant lacking exon 13, is aligned with its site of divergence from p73␣. (C) Homology between the C-terminal sequence of p73␣ and that of a p53-like protein from squid.
(D) Summary of yeast two-hybrid interaction assays between p53, p73␣, and p73␤, presented as ordinate values relative to B-galactosidase activity of p53-p53 interactions. , 1996) are conserved and occupy identical positions in p73 (Figure 1a) . No significant homology was Homology between p73 and the p53 detected between the C-terminal domain (364-393) of Tumor Suppressor mammalian p53 and p73. However, the C-terminal do-A cDNA encoding p73 was fortuitously discovered in a main of human p73␣ shows homology with recently dishybridization screen of a COS cell cDNA library using covered invertebrate p53 homologs (Figure 1c ), sugdegenerate oligonucleotides corresponding to IRS-1-gesting the possibility that p53 may have evolved from binding domains. The coding sequence of p73 was a more primitive, p73-like gene. In support of this confound to lack any homology to IRS-1 binding domains.
Results

Prives
cept, the intron-exon organization of the p73 gene was Subsequently, libraries of normal human colon tissue found to be similar to that of the p53 gene ( Figure 1a ). cDNAs were screened by hybridization to yield cDNAs p73␤ is encoded by transcripts lacking the 96 nucleoencoding p73␣ and p73␤, which are splicing variants of tides corresponding to exon 13. This deletion interrupts p73 differing at their C termini (Figures 1a and 1b) . The the open reading frame, yielding a polypeptide of 499 homology between p73 and p53 is extensive within the amino acids (Figure 1b ). Both p73␣ and ␤ transcripts most conserved p53 domains (Zambetti and Levine, were detected by PCR in all human tissues tested, in-1993; Ko and Prives, 1996) involved with transactivation cluding brain, kidney, placenta, colon, heart, liver, spleen, (29% identity with p53 amino acids 1-45), DNA binding and skeletal muscle (data not shown), indicating a wide-(63% identity with p53 amino acids 113-290), and p53 spread, albeit low level, expression of these proteins. oligomerization (38% identity in p53 sequence from Considering the extensive homology between p53 319-363) (Figures 1a and 1c) . While the homology beand p73, including that in the oligomerization domain tween the N terminus of p73 and that required for tranof p53, we assessed whether these proteins would interscriptional activation by p53 is not strong, a sequence act in the context of the yeast two-hybrid system (Gyuris similar to the MDM2-binding domain of p53 (TFSDLW; . Using this assay, we detected strong homo- Lin et al., 1994a ) is present in p73 as TFEDLW. Signifitypic interactions between p53 molecules, indicative of cantly, residues corresponding to those of p53 fretheir known ability to form oligomers (Ko and Prives, quently mutated in tumors (R175, G245, R248, R249, 1996) . In contrast, p73␣ showed a very low tendency R273, and R282) and shown to be required for sequencespecific DNA recognition (Lin et al., 1994b ; Ko and to form homotypic interactions in this assay. However, arm of chromosome 1 appear frequently in neuroblastoma (Takeda et al., 1994; Caron et al., 1995; , we performed p73 FISH analysis on various human cell lines established from neuroblastoma tumors. The SK-N-AS has the smallest 1p deletion of defined neuroblastoma cell lines covering approximately 8 Mb, limited distally by D1Z2 (1p36.33) and proximally by TNFR2 (1p36.2) (Figure 2b ; White et al., 1995; Cheng et al., 1996) . Probing of SK-N-AS with the p73 gene yielded signal from only one of the two chromosome 1 homologs, demonstrating a p73 LOH in this neuroblastoma cell line (Figure 2a) . Subsequent, more detailed mapping has indicated that the p73 gene is very close to the D1Z2 marker at 1p36.33, thereby placing p73 at the distal border of the consensus region of deletion in neuroblastoma ( Figure 2b) . A similar FISH analysis of neuroblastoma cell lines showing N-Myc amplification and a larger 1p deletion, including IMR-32 and CHP-212, confirmed the LOH of the p73 gene in these cells (Table 1) . Interestingly, both the SK-N-SH and the SK-N-MC neuroblastoma cell lines show neither 1p (Davidoff et al., 1992; Cheng et al., 1996) nor p73 LOH ( Table 1 ), indicating that either other lesions are responsible for these tumors or that p73 is inactivated by mechanisms besides deletions in these cell lines. . Approximate analysis was performed on these same cell lines. Two positions of genes (in red) and polymorphic markers (in black) are p73 transcripts of 4.4 and 2.9 kb, corresponding to polynoted. adenylation variants as determined by direct sequencing, were detected in HT-29, IMR-32, and SK-N-SH mRNA, while p73 transcripts were either not detected p73␤ displayed strong homotypic interactions, equivain RNA from SK-N-AS cells or present at exceeding lent to that of p53. The potential for heterotypic interaclow levels in SK-N-MC cells (Figure 3b , upper panel). tions was also assayed by the two-hybrid system. InterCorresponding Northern analysis of p53 transcripts in estingly, p53 and p73␤ displayed significant mutual these cell lines revealed a common 2.5 kb transcript interactions in either bait or prey configuration, while except for SK-N-MC, which displays a previously charp53 showed negligible interactions with p73␣. Weak but acterized truncation ( Figure 3b , lower panel; Davidoff et detectable interactions between p73␣ and p73␤ were al., 1992). Western blots to detect the p73␣ protein were also evident in this assay. The physiological significance performed using a polyclonal antibody directed against of the apparent oligomerization and restricted heterothe C terminus of p73␣. Reflecting the Northern data for typic interactions amongst p73␣, p73␤, and p53 deterp73 transcripts in these cell lines, extracts from HT-29, mined in these assays remains to be established.
IMR-32, and SK-N-SH cells showed easily detectable levels of the p73␣ protein. However, SK-N-MC and SK-N-AS extracts contained significantly reduced levels of p73 Gene Localized to Neuroblastoma Suppressor Locus at 1p36 p73␣, showing only a faint band that migrates somewhat faster than the main product seen for HT-29, IMR-32, To test the possibility that the p73 gene was located at sites of suspected tumor suppressor genes, we mapped and SK-N-SH ( Figure 3c ). To characterize further the expression pattern of p73, we performed immunolothe p73 gene using fluorescence in situ hybridization (FISH) on normal human chromosome spreads. The p73 calization of the endogenous p73␣ in an array of cell lines, all of which revealed a pattern of small, punctate cosmid probe hybridized to the subtelomeric p36 region of chromosome 1 (Figure 2a ). As deletions in the short dots in the nucleus of some cells in an asynchronous 
1 1p⌬, deletion in short arm of chromosome 1, as cited in text. NR, none reported. 2 Determined by fluorescence in situ hybridization (FISH) with a p73 genomic probe on chromosome spreads, performed as described in Experimental Procedures. NT, not tested. 3 Determined by FISH analysis with the chromosome 1 centromeric probe, D1Z5 (Oncor). NT, not tested. 4 Refers to the polymorphism of G/C and A/T alleles, as determined by PCR on genomic DNA and PCR-RL (see Figure 4 and Experimental Procedures) of products. Minus sign (Ϫ) indicates p73 loss of heterozygosity, assumed on the basis of known 1p36 deletions. For cell lines in which chromosome 1p deletions have not been reported (NR), the A/T allele was never detected, though the presence of other non-G/C or A/T alleles cannot be formally excluded (denoted by question mark). 5 Determined by RT-PCR on mRNA and subsequent sequencing of products. Asterisks indicate a second, 30-cycle round of PCR was required to generate products for sequencing. (-) indicate a lack of detectable product, despite two rounds of RT-PCR. 6 Determined by sequence analysis of open reading frame in expressed transcripts. wt, wild type compared with normal human tissue (not shown); N/A, not available due to lack of mRNA expression, as determined by RT-PCR. ␦ indicates 10% of transcripts sequenced contained a deletion in exon 2. 7 Detectable by Western blotting of whole cell lysates, as described in Figure 3 and Experimental Procedures. 8 Same as 6, performed on p53 mRNA. population ( Figure 3d) . A similar distribution of dots was from control, nonneuroblastoma lines, were sequenced in their entirety and found to be identical to p73 serevealed upon transfecting mammalian cells with a myc epitope-tagged p73␣ expression vector, indicating that quences derived from normal human tissue (Table 1) . Western blot analysis of the four neuroblastoma lines p73 autonomously targets to these intranuclear foci (Figure 3d) . that showed extremely low levels of p73 transcript by RT-PCR revealed a corresponding lack of p73␣ protein (Table 1 ). In addition, two neuroblastoma lines, SK-NLack of Coding Region Mutations in p73 Gene As most neuroblastoma cell lines examined displayed BE(2) and SK-N-MC, showed detectable levels of p73 transcripts by one round of PCR but no p73␣ protein. a LOH of the p73 gene, we asked whether the remaining allele sustained genetic changes that might affect p73
These results, together with the absence of mutations in the remaining allele of p73 LOH neuroblastoma cell function. We used the p73 RT-PCR reaction to amplify the coding region of p73 from mRNA of an extended lines, suggest that epigenetic mechanisms such as imprinting and translational suppression act to limit p73 group of neuroblastoma cell lines. As with SK-N-AS, the neuroblastoma lines SMS-BC, CHP-212, and SMS-KAN expression in neuroblastoma cells. showed no RT-PCR product corresponding to p73 after 30 cycles, suggesting very low expression levels. HowMonoallelic Expression of the p73 Gene Through our analysis of p73 transcripts in neuroever, reamplification for an additional 30 cycles yielded sufficient product for sequencing p73 transcripts from blastoma cell lines and tumors, we discovered an allelic polymorphism consisting of a double nucleotide substithese lines. These PCR products, including six from neuroblastoma cell lines displaying a 1p36 LOH (IMR-32, tution (G→A) and (C→T) at positions 4 and 14 of exon 2, just upstream of the initial AUG of p73 ( Figure 4a ). CHP-212, SMS-BC, SMS-KAN, SK-N-BE(2), and SK-N-AS), two from neuroblastoma cell lines that showed no
We denote these two naturally occurring p73 alleles G/C and A/T. The G/C, A/T polymorphism occurs in a region 1p deletion (SK-N-SH and SK-N-MC), as well as those over the other. We addressed this issue by performing the assay on G/C and A/T transcripts mixed at known ratios and showed that this assay was not obviously biased for one allele. Moreover, this analysis showed that we could detect both transcripts even when they are present in ratios of 20:1 (Figure 4d ). To examine further the possibility of monoallelic expression of p73, we performed PCR-RL on transcripts of peripheral blood cells from five healthy donors determined to be G/C;A/T heterozygotes. All five PCR-RL assays revealed a p73 pattern corresponding to either, but not both, the A/T or the G/C allele, supporting the notion of monoallelic expression of p73, at least within the 20-fold sensitivity of this assay (Figures 4c and 4d) . Thus, monoallelic expression of p73 may have particular significance for neuroblastoma and other tumors that display 1p36 LOH, as deletion of the active allele may result in a nearly complete loss of p73 activity. Finally, p73␣ protein expression was easily detected in a majority of nonneuroblastoma cell lines. In contrast, only two of eight neuroblastoma cell lines yielded p73␣ signal on Western analysis. Lysates from the transfected cells were probed with antibodies to detect the expression of p73 or p53 as well as p21 waf , a known p53 target gene (El-Deiry et of the transcript that could theoretically form a stemloop structure, possibly an indication of regulatory funcal., 1993) . Significantly, cells expressing wild-type p73 showed elevated levels of p21 protein, comparable to tion. Interestingly, sequencing of p73 transcripts from a wide variety of nonneuroblastoma cell lines, listed in those seen in wild-type p53 transfectants, whereas mutant p73-and mutant p53-expressing cells both failed Table 1 , revealed only the G/C allele, while three of eight neuroblastoma lines possessed an A/T allele. We used to show a similar p21 waf induction (Figure 5a ). We further tested the effect of exogenously expressed PCR-restriction length analysis (PCR-RL) to screen rapidly for allele types at both the DNA and transcript levels, p73 on SK-N-AS cells using a standard colony assay (Baker et al., 1990) . Identical sets of plates to those taking advantage of the additional Sty1 site resulting from the double substitution (G→A and C→T) in exon 2 above were maintained under G418 selection for 3 weeks and assayed for colony production. No colonies (Figures 4b and 4c) . Notably, the single remaining allele of both IMR-32 and CHP-212 bears the A/T polymorwere obtained from cells expressing wild-type p73 or p53 (Figure 5b ), while the DNA-binding domain mutants phism (Table 1) . We were especially intrigued by the analysis of the SK-N-SH cell line, which shows no p73 of each yielded high numbers of colonies. Although the physiological significance of colony assays in general LOH and has both G/C and A/T alleles at the genomic level. At the transcript level, however, using RT-PCRis unclear, the obvious distinction between the wildtype versions of p73 and p53 and their counterpart mu-RL, we could only detect expression of the A/T allele (Figure 4c ). This result suggested that, at least in SKtants that fail to bind DNA suggests that the observed growth suppression and endogenous p21 activation in N-SH cells, p73 protein is a consequence of monoallelic expression. Another possibility that might explain this SK-N-AS cells are a function of the transcription activity of p73 and p53. result is that our RT-PCR-RL assay may favor one allele (A) Sequence of exon 2 alleleic variants of p73␣ transcripts deduced from RT-PCR product sequencing. The two alleles, which represent dinucleotide substitutions at position 4 and 14 of exon 2, are G4/C14 and A4/ T14 and appear at a region of the 5Ј-untranslated sequence that might form a stem-loop structure.
(B) Genotypic analysis of p73 G/C and A/T alleles in ten normal blood donors using PCR-RL. Genomic PCR products that include exon 2 yield a 482 bp fragment. Sty1 digestion of PCR products yields two smaller size fragments from AT allele-derived amplicons of 376 bp and 106 bp, respectively, whereas the GC allele-derived amplicons remain uncut (lanes 1, 2, 3, 4, 6, 7, and 10). The lanes 5, 8, and 9 show heterozygotes GC/AT donors. (C) Analysis of G/C A/T p73 allele expression using Sty1 and Nar1 digestions of transcript RT-PCR products from cell lines and five p73 heterozygote GC/AT individuals (1-5). As with the genomic analysis, the double digestion of RT-PCR products yields specific fragments identitying each type of allele transcript-derived amplicons (284 bp The identification of a novel gene located at chromoIn light of the structural similarities between p73 and some 1p36.2-3 that encodes proteins with significant p53, we asked whether p73, like p53, is induced by homology to p53 may have implications for our underagents that activate the DNA damage checkpoint (Ko standing of the etiology of neuroblastoma and other and Prives, 1996) . To do this, p53 and p73 protein levels tumors as well as for p53 evolution and function. The were assayed in IMR-32 cells following exposure to eiremarkable homology between the core domain of p73 ther actinomycin D or ultraviolet radiation (Kessis et and the DNA-binding domain of p53, together with p73 's al., 1993; Caelles et al., 1994) . Actinomycin D at low ability to induce the p21 waf protein, suggest that p73 concentrations (1 nM) activates the DNA damage checkacts, in part, as a transcription factor. While it is not point through producing DNA strand breaks, while at obvious that p73 and p53 share common functions, the higher concentrations (1 to 2 M) inhibits transcription presence of distal 1p alterations in a wide array of tumors (Kessis et al., 1993; Caelles et al., 1994) . After 24 hrs of in addition to neuroblastoma, including melanoma (Dratreatment with 1 nM actinomycin D, p53 and p21 waf levels copoli et al., 1989), hepatocellular carcinoma (Yeh et al., in the cell are markedly elevated, while p73␣ levels ap-1994), and ductile breast carcinoma (Genuardi et al., pear unaffected (Figure 6a ). At micromolar concentra-1989), supports the notion that p73 operates in pathtions of actinomycin D that inhibit transcription, p53
ways that coordinate cell growth, death, and differentilevels continue to rise above those of untreated cells, ation. presumably due to a stabilization of the p53 protein. Neuroblastoma is thought to arise from primitive neuTo assess further the effect of DNA damage on p73␣ roectodermal stem cells that fail, at various stages, to levels, IMR-32 cells were exposed to ultraviolet (254 nm) differentiate into sympathetic neurons, Schwann cells, radiation and subsequently probed with antibodies to or melanocytes (Knudson and Meadows, 1980; Ross et p73␣, p53 , and p21. Although p53 protein was markedly al., 1995). Associated cytogenetic characteristics inincreased in cells at 15 hrs after irradiation, p73␣ levels clude discrete and gross deletions of the short arm of fail to show a similar increase after such treatments chromosome 1, the amplification of N-Myc, and distur- (Figure 6b) . A similar failure to induce p73␣ was obbances in cell ploidy (Takeda et al., 1994 ; Ambros et al., served in cells exposed to gamma radiation or genotoxic 1995; Caron et al., 1995; . Genetic agents such as doxorubicin (data not shown). Thus, analyses of neuroblastoma tumors harboring discrete despite the structural similarities between p73 and p53 1p36.2-3 LOH have shown this deletion to be sustained and their common ability to induce p21 waf , these proteins predominantly by the maternally derived chromosome, do not respond in a similar manner to DNA damaging thereby implicating one or more imprinted tumor suppressor genes in this region . In events. al., 1995; Versteeg et al., 1995) . The disruption of p73, which lacks detectable 1p or p73 LOH, and IMR-32, which harbors a large 1p35-36 deletion characteristic of N-myc-amplified neuroblastomas. Notably, sequence analysis of p73 transcripts in both SK-N-SH and IMRcontrast, the more aggressive stage 3 and 4 neuroblastomas appear to have amplified N-Myc and have 32 revealed a dinucleotide A/T polymorphism in the 5Ј untranslated region. Using this polymorphism, we demsustained larger telomeric deletions, including 1p36 and 1p35 from chromosome 1 of random parental origin onstrated monoallelic expression of the p73 gene not only in cell lines but also in peripheral blood cells of . Whether 1p35 harbors additional tumor suppressor genes or one that affects N-Myc amnormal donors. To date, we have analyzed only one informative family regarding the parental dominance in plification or modifies expression of other genes on 1p is unknown, but it is obvious that neuroblastoma is a expression of p73 alleles. In this case, a normal A/T;G/C heterozygote donor was found to express the A/T allele highly complex and heterogeneous disease involving the disruption of activities at multiple loci.
at the transcript level, while the maternal and paternal genotypes were A/T;A/T and G/C;G/C, respectively The chromosomal localization and monoallelic expression of p73, its frequent LOH in neuroblastoma, (data not shown). While obviously limited, this analysis shows a case in which the p73 gene, like the putative and its conspicuous lack of expression in a majority of neuroblastoma cell lines are all consistent with the notumor suppressor at 1p36, is expressed predominantly from the maternal allele. Further, is there any signifition that p73 is a candidate for the putative, imprinted neuroblastoma suppressor gene at 1p36. Importantly, cance to the observation that in the only two neuroblastoma lines examined with p73 protein expression, p73 maps to the distal border of the consensus deletion found in neuroblastoma, as defined by a wide range of namely IMR-32 and SK-N-SH, this protein was derived from an A/T transcript? At present, we have no experitumor cell lines . It is interesting to note, however, that a constitutional 1p36 deletion in one mental evidence for a functional difference between the G/C and A/T alleles. We note, however, that the p73 case reportedly retained the D1Z2 marker at 1p36.33 (Biegel et al., 1993) . This potentially places p73 immeditranscripts contain an in-frame CUG codon 5Ј of this polymorphic region, which, at least in several genes, ately distal to the region of overlap between the constitutional case and deletions in neuroblastoma tumor cell including basic fibroblast growth factor and C-Myc, acts as an alternative translation initiation codon (Prats et lines. It remains possible, nonetheless, that the constitutional deletion encompasses a region extremely close al., 1989). Moreover, conceptual translation from this CUG codon yields a coding sequence somewhat homolto p73 and could mediate its disruption without a strict deletion of the gene. On the other hand, various studies ogous to that of the transcriptional activation domain of p53. We are presently investigating the possibility have reported tumor cell lines and constitutional translocations at 1p36 whose break points do not map within that this 5Ј CUG codon is in fact an alternative site for the initiation of p73 translation. the deletion in SK-N-AS. This has led to the speculation that multiple neuroblastoma suppressor genes exist at
In this study, we concentrated on neuroblastoma cell lines showing 1p LOH and found that the remaining p73 1p36 (Takeda et al., 1994; Amler et al., 1995 ; Laureys et allele lacked mutations similar to those that inactivate activities of p53 in cell growth regulation or promote survival of a disregulated cell. Importantly, recent studp53. However, as only ‫%03ف‬ to 40% of sporadic neuroblastoma tumors display an obvious 1p LOH (Caron et ies have begun to establish links between active cell cycle progression and differentiation (Huttner and Brand, al., 1995) , an extensive analysis of neuroblastoma tumors will be required to determine the actual signifi-1997), thereby suggesting a potential mechanism by which p73 might be required for differentiation of neucance of p73 lesions, monoallelic expression, and the A/T polymorphism in the development of neuroblastoma roectodermal stem cells. Analysis of p73 activity during differentiation and throughout the cell cycle should proand other diseases.
vide insight into these issues. It is unclear at present how the identification of this p73 Function The identification of p73, its homology with p53, and its novel gene will impact on our understanding of p53.
From an evolutionary standpoint, however, it is interestlink to tumor suppressors at 1p36 raise fundamental questions regarding p73 function in development and ing to note that p73 shares greater homology with p53-like proteins found in mollusks than with p53 itself. It is cell cycle control. Does p73, for instance, act in a manner similar to p53 to sense cellular stresses such as DNA formally possible that p53 evolved from a more primitive, p73-like gene involved in many aspects of differentiation damage and hypoxia and integrate this information for cell cycle and cell death regulation? Whereas p73 is and growth control to assume more specific functions in cell cycle control and tumor suppression. It is also shown to be capable of enhancing levels of endogenous p21 waf protein, it is not induced in cell lines by agents, possible, given the general quadruplication of the Hox complex and other essential genes at the chordateincluding UV radiation and actinomycin D, that result in p53 stabilization and activation. Although experiments vertebrate transition (Holland, 1996) , that other p53-like genes exist and comprise a p53 regulatory network. are under way to determine what signals influence p73 expression, it is apparent that p73 and p53 may be Finally, the discovery of a gene related to p53 will likely contribute to our understanding of the complex serving distinct functions in the cell. An equally pressing question is whether p73 and p53 interact to yield novel etiology of neuroblastoma and other diseases involving 1p LOH and may lead to new avenues in developmental activities not displayed by either molecule alone. Given the dramatic consequences of heterodimerization by and cell cycle regulation, tumor biology, and alternate strategies for cancer therapy. members of the c-Myc family (c-Myc, Myb, Max, and Mxi1) on target gene expression (Bernards, 1995) , it will be important to determine if such interactions occur p73␣ has a very low propensity for self interactions in this assay. Moreover, p73␤ displays an ability to interact Two-Hybrid Assay with both p73␣ and p53, despite its preferential associaThe two-hybrid assay was performed essentially as described (Gytion with other p73␤ molecules. Although we are pres- uris et al., 1993) . Nucleotide sequences corresponding to amino ently examining p73-p53 interactions in a variety of cells, studies indicate that it is aberrantly cytoplasmic (Moll et al., 1995) . An intriguing, though speculative, explanap21 waf Protein Induction Assay tion for this unusual behavior of p53 in neuroblastoma p73 cDNAs were cloned into a pCMV1 vector containing a 200 bp lamin 5Ј-untranslated region and encoding an N-terminal myc tag is that p53 requires p73 for some activities that are lost (Heald et al., 1993) . pCMV-p53 and pCMV-p53V143A were gifts of in the absence of p73. Definitive answers to whether p73
Dr. Bert Vogelstein (Baker et al., 1990) . IMR-32 cells were transfected has consequential interactions with p53 will obviously on 100 mm plates with 20 g of the indicated plasmid and extracts require extensive genetic and biochemical studies.
prepared by lysis in SDS sample buffer. Lysates were fractionated Major questions remain for understanding possible on a 10% polyacrylamide gel and transferred to Immobilon memp73 functions in cell cycle regulation and growth control.
branes by electrophoresis. Membranes were probed with a p21
Curiously, the majority of nonneuroblastoma tumor cell polyclonal antibody (Calbiochem) and developed by chemiluminescence (Pierce).
lines was found to express high levels of wild-type p73 transcript and protein, suggesting a role for p73 in prolif-
DNA Damage Response
eration. This observation is perplexing in that most norCell lines, including IMR-32, MCF-7, and SK-N-SH, were grown to mal tissues show low levels of p73 transcript and protein 50% confluence and incubated with either 1 nM or 1 M actinomycin (data not shown). One possible explanation for elevated Bethesda), or a monoclonal antibody to p21 (Calbiochem). For ex-5ЈCACCTGCTCCAGGGATGC and 5ЈAAAATAGAAGCGTCAGTC derived from intronic sequences were employed. For PCR-2, 2 ml of amining responses to ultraviolet radiation, media was removed from plates and cells exposed to 20 and 100 Joules/m 2 254 nm UV-C. purified PCR-1 reaction products were used with a more internal set of primers (5ЈCAGGCCCACTTGCCTGCC and 5ЈCTGTCCCCAAG Media was returned to the plates and cells grown for an additional 15 hrs prior to lysis and Western blotting, as above.
CTGATGA). The resulting amplicons were Sty1 digested and analysed on 1.5% agarose gels.
Fluorescence in Situ Hybridization (FISH)
The p73 cosmid probe was labeled by nick translation using biotin
